Neurotech International Limited Stock
Equities
NTI
AU000000NTI9
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.095 AUD | -5.00% | -9.52% | +37.68% |
Apr. 17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
Apr. 17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
Sales 2022 | 608K 392K | Sales 2023 | 1.19M 770K | Capitalization | 34.96M 22.53M |
---|---|---|---|---|---|
Net income 2022 | -3M -1.93M | Net income 2023 | -7M -4.51M | EV / Sales 2022 | 77.3 x |
Net cash position 2022 | 1.9M 1.22M | Net cash position 2023 | 5.03M 3.24M | EV / Sales 2023 | 25.1 x |
P/E ratio 2022 |
-14.5
x | P/E ratio 2023 |
-4.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 68.48% |
1 day | -5.00% | ||
1 week | -9.52% | ||
Current month | -13.64% | ||
1 month | +1.06% | ||
3 months | +25.00% | ||
6 months | +63.79% | ||
Current year | +37.68% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Operating Officer | - | 22-03-07 | |
Erlyn Dawson
SEC | Corporate Secretary | - | 19-04-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Winton Willesee
BRD | Director/Board Member | 53 | 19-04-15 |
Mark Davies
CHM | Chairman | - | 19-04-15 |
Thomas Duthy
BRD | Director/Board Member | - | 22-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 0.095 | -5.00% | 5 487 842 |
24-04-17 | 0.1 | -4.76% | 9,450,795 |
24-04-12 | 0.105 | 0.00% | 1,828,584 |
24-04-11 | 0.105 | 0.00% | 566,547 |
24-04-10 | 0.105 | +5.00% | 269,400 |
Delayed Quote Australian S.E., April 18, 2024 at 02:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+37.68% | 58.89M | |
-11.11% | 154M | |
-14.44% | 82.65M |
- Stock Market
- Equities
- NTI Stock